Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
08/04/2026 22:10
April 8 (Reuters) - Phio Pharmaceuticals Corp PHIO.O: PHIO PHARMACEUTICALS CORP - ENTERS AT THE MARKET OFFERING AGREEMENT WITH H.C. WAINWRIGHT ON APRIL 8, 2026 - SEC FILING PHIO PHARMACEUTICALS CORP - TO OFFER UP TO $6.36 MILLION OF SHARES UNDER SALES AGREEMENT - SEC FILING Source text: [ID:n0001437749-26-011761] Further company coverage: PHIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phio Pharmaceuticals
See all newsPhio Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: Phio Pharmaceuticals Corp - Enters At The Market Offering Agreement With H.C. Wainwright On April 8, 2026
Brief: Phio Pharmaceuticals Corp Announces Key Tumor Response Data From PH-762 Trial
Brief: Phio Pharmaceuticals Corp To Begin Toxicology Study For Ph-762 Before Human Trials - SEC Filing
Brief: Phio Pharmaceuticals Corp Files For Offering Of Up To 11.8 Million Common Shares By The Selling Stockholders - SEC Filing